These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1017163)

  • 21. Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.
    Bühler FR; Laragh JH; Baer L; Vaughan ED; Brunner HR
    N Engl J Med; 1972 Dec; 287(24):1209-14. PubMed ID: 5084985
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renal insufficiency and renin-angiotensin-aldosterone].
    Ishii M; Ikeda T; Yagi S
    Nihon Rinsho; 1974 Mar; 32(3):518-27. PubMed ID: 4368245
    [No Abstract]   [Full Text] [Related]  

  • 23. [Essential hypertension and the renin-angiotensin-aldosterone system].
    Kokot F
    Kardiol Pol; 1975; 18(3):209-18. PubMed ID: 1142580
    [No Abstract]   [Full Text] [Related]  

  • 24. [Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
    Khristov V; Maleeva A; Turkolev N
    Vutr Boles; 1980; 19(4):28-31. PubMed ID: 6998133
    [No Abstract]   [Full Text] [Related]  

  • 25. [Equilibration of the treatment of severe arterial hypertension. Significance of d-1 propranolol].
    Ménard J; Corvol P; Alexandre JM; Meignan M; N'Guyen-Phanh-Tam
    Nouv Presse Med; 1975 Jan; 4(1):17-20. PubMed ID: 806894
    [No Abstract]   [Full Text] [Related]  

  • 26. Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
    Bühler FR; Laragh JH; Vaughan ED; Brunner HR; Gavras H; Baer L
    Am J Cardiol; 1973 Sep; 32(4):511-22. PubMed ID: 4729721
    [No Abstract]   [Full Text] [Related]  

  • 27. Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.
    Biollaz J; Brunner HR; Gavras I; Waeber B; Gavras H
    J Cardiovasc Pharmacol; 1982; 4(6):966-72. PubMed ID: 6185790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of guanabenz on arterial pressure and the renin-aldosterone system in hypertensive patients].
    Rappelli A; Glorioso N; Tedde R; Madeddu P; Dessì Fulgheri P; Campus S
    Boll Soc Ital Cardiol; 1978; 23(1):177-83. PubMed ID: 754771
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma angiotensin II, renin, renin-substrate and aldosterone concentrations in acute renal failure in man.
    Paton AM; Lever AF; Oliver NW; Medina A; Briggs JD; Morton JJ; Brown JJ; Robertson JI; Fraser R; Tree M; Gavras H
    Clin Nephrol; 1975 Jan; 3(1):18-23. PubMed ID: 1126059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.
    Laragh JH
    Am J Med; 1973 Sep; 55(3):261-74. PubMed ID: 4355699
    [No Abstract]   [Full Text] [Related]  

  • 31. [Responses of renin-angiotensin-aldosterone system to insulin hypoglycemia in patients with essential hypertension (author's transl)].
    Ishimaru K; Saito H; Oshima I; Saito S; Susaki S; Matsuda M; Mori H
    Nihon Jinzo Gakkai Shi; 1978 Oct; 20(10):1087-93. PubMed ID: 732035
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of pindolol and propranolol on plasma renin and aldosterone in patients with renal allograft.
    Wehling M; Kuhlmann U; Záruba K; Largiadèr F; Keusch G; Studer A; Vetter W
    Clin Nephrol; 1983 Nov; 20(5):231-4. PubMed ID: 6360452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
    Shibata H; Suzuki H; Murakami M; Sato A; Saruta T
    J Hypertens; 1994 Nov; 12(11):1275-84. PubMed ID: 7868875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin-angiotensin-aldosterone system, RR interval, and blood pressure variability during postural changes in borderline arterial hypertension.
    Duprez DA; De Sutter JH; De Buyzere ML; Rietzschel ER; Rimbaut S; Kaufman JM; Van Hoecke MJ; Clement DL
    Am J Hypertens; 1995 Jul; 8(7):683-8. PubMed ID: 7546493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal hypertension (author's transl)].
    Omae T
    Nihon Naika Gakkai Zasshi; 1978 Feb; 67(2):133-44. PubMed ID: 349100
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of plasma renin activity and urinary excretion of aldosterone in patients with essential hypertension treated with D-L propranolol].
    Bompiani GD; Scaduto P; Galluzzo A; Morici ML; Mangano MT; Donatelli M
    Minerva Cardioangiol; 1976; 24(7-8):498-505. PubMed ID: 1018743
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients.
    Stokes GS; Weber MA; Thornell IR; Stoker LM
    Prog Biochem Pharmacol; 1974; 9():29-44. PubMed ID: 4612559
    [No Abstract]   [Full Text] [Related]  

  • 38. [Relationship between the renin-angiotensin-aldosterone system and CNS in the etiology of hypertension].
    Hartrodt W; Brosowski KH; Baumann R
    Dtsch Gesundheitsw; 1971 Feb; 26(6):237-43. PubMed ID: 4328786
    [No Abstract]   [Full Text] [Related]  

  • 39. [Catecholamines in the blood and the renin-angiotensin-aldosterone axis in essential hypertension].
    Cerasola GA; Morici ML; Andronico G; Picciotto G; Cottone S; Bucalo M
    Boll Soc Ital Cardiol; 1981; 26(12):2279-91. PubMed ID: 6764360
    [No Abstract]   [Full Text] [Related]  

  • 40. [Renin-angiotensin-(aldosterone)-system-clinical aspects].
    Börner H
    Z Gesamte Inn Med; 1973 Dec; 28(24):757-62. PubMed ID: 4360460
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.